Breast cancer survivors face physical, psychological, and practical challenges that can persist for years after treatment completion.
These survivor issues stem from the cancer itself, treatment modalities of surgery, radiation, chemotherapy, targeted therapy, and endocrine therapy, and the transition from active treatment to long-term survivorship.
Lymphedema affects approximately 20% of women after axillary lymph node dissection and 5.6% after sentinel lymph node biopsy.
Chronic pain develops in about one-third of survivors, particularly affecting younger women and those who underwent axillary lymph node dissection.
Chemotherapy-induced peripheral neuropathy from taxanes persists long-term in many patients.
Cardiotoxicity requires ongoing monitoring in survivors who received anthracyclines, HER2-targeted therapy, or left-sided radiation.
Almost 20% of the 3 million breast cancer survivors have cardiovascular disease.
Heart failure and cardiomyopathy are the most common cardiovascular, toxic effects in patients treated for breast cancer, and are associated with increased symptom burden, adversely affecting quality of life.
Premature menopause from chemotherapy or ovarian suppression therapy leads to vasomotor symptoms (hot flashes, night sweats), vaginal dryness, and increased osteoporosis risk.
Women on aromatase inhibitors should have baseline and periodic bone mineral density monitoring.
Cognitive dysfunction and fatigue are frequently reported, with survivors experiencing difficulties with multitasking, memory, and attention that can interfere with daily activities.
Sexual dysfunction is common, due to hormonal changes, body image concerns, and treatment-related vaginal symptoms.
Psychological and Psychosocial Concerns
Anxiety, and depression and fear of recurrence represent major concerns that may persist for many years after diagnosis.
Body image concerns following surgery affect quality of life and sexual health.
Most breast cancer survivors who report concerns of physical, emotional problems do not receive adequate support, with two-thirds of those facing concerns experiencing unmet needs.
Regular follow-up includes history and physical examination 1-4 times yearly for 5 years, then annually, with annual mammography beginning 6+ months after breast-conserving therapy.
Routine imaging or laboratory screening for metastases in asymptomatic patients is not indicated.
Breast cancer survivors should maintain healthy lifestyle habits: achieving and maintaining ideal body weight (BMI 20-25), engaging in regular physical activity, consuming a diet rich in vegetables and fruits, limiting alcohol intake, and avoiding tobacco.
Fertility concerns relevant for younger survivors, as chemotherapy and endocrine therapy can impair fertility.
Fertility counseling should be offered to all premenopausal patients.